A breakthrough on cancer therapy by inhibition of negative immune regulation: nobel prize in physiology or medicine 2018

dc.creatorSoren, Karuna
dc.creatorKabiraj, Ashutosh
dc.creatorGoswami, Prittam
dc.creatorBanerjee, Aparna
dc.creatorBandopadhyay, Rajib
dc.date2023-05-16T14:52:49Z
dc.date2023-05-16T14:52:49Z
dc.date2020
dc.date.accessioned2024-05-02T20:31:15Z
dc.date.available2024-05-02T20:31:15Z
dc.identifierhttp://repositorio.ucm.cl/handle/ucm/4781
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/9275024
dc.descriptionJames P. Allison from the MD Anderson Cancer Center, University of Texas, and Tasuku Honjo from Kyoto university were jointly awarded the prestigious Nobel Prize in Physiology/Medicine 2018. Their therapeutic research is on the inhibition of CTLA-4 and PD-1, two proteins which act as a blockade and prevent the immune system from attacking tumor cells.
dc.languageen
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 Chile
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.sourceNational Academy Science Letters, 43(7), 681-685
dc.subjectCancer therapy
dc.subjectNegative immune regulation
dc.subjectNobel prize
dc.subjectPhysiology/medicine
dc.titleA breakthrough on cancer therapy by inhibition of negative immune regulation: nobel prize in physiology or medicine 2018
dc.typeArticle


Este ítem pertenece a la siguiente institución